Based on our first half numbers (H1 FY24), we were "entitled" to a dividend of approximately A$0.03, but the BOD decided to hold the money, due to market conditions. As much as I like getting paid dividends, under the market conditions in early January, when that decision was made, I agreed with them, wholeheartedly.
Since spot prices for SC6, and, I would assume, PLS' financials, will look better in H2, which ends in just over a month, I would guesstimate that we would be "due" for a dividend in the A$0.05 range for H2.
PLS' BOD has been very conservative, so we might not see anything in the way of a year-end dividend. Personally, I'd like to see them give us whatever we've "earned" for H2, which I'm assuming will be approximately A$0.05, but I also think that the market would react well to us being paid our "full" year-end dividend of, assuming my numbers are accurate, A$0.08 (the amount we earn in H2 and the amount we were "due" in H1, but which they withheld).
I know we should have an idea of how Q4 went, and by extension, what our year end numbers SHOULD look like, but I believe we won't see our actual year end earnings statement until the last week in August, so it will be a while before we know who's dart hit the correct target.
Best regards,
- Forums
- ASX - By Stock
- PLS
- Good News & Bad News
Good News & Bad News, page-43097
-
- There are more pages in this discussion • 1,299 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
|
|||||
Last
$3.00 |
Change
-0.020(0.66%) |
Mkt cap ! $9.045B |
Open | High | Low | Value | Volume |
$3.02 | $3.04 | $3.00 | $13.79M | 4.545M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 63950 | $3.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.01 | 176126 | 51 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
36 | 279743 | 3.000 |
50 | 455788 | 2.990 |
38 | 371132 | 2.980 |
28 | 212945 | 2.970 |
37 | 376017 | 2.960 |
Price($) | Vol. | No. |
---|---|---|
3.010 | 131068 | 40 |
3.020 | 433295 | 37 |
3.030 | 355472 | 32 |
3.040 | 197118 | 30 |
3.050 | 313041 | 21 |
Last trade - 11.07am 16/07/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online